Publikationen, an denen er mitarbeitet Antonio Pérez Martínez (24)

2020

  1. COVID-19 infection in children and adolescents with cancer in Madrid

    Pediatric Blood and Cancer

2017

  1. Early clinical trials in paediatric oncology in Spain: a nationwide perspective

    Anales de Pediatria, Vol. 87, Núm. 3, pp. 155-163

  2. Ensayos clínicos precoces en oncología pediátrica en España: una perspectiva nacional

    Anales de Pediatría: Publicación Oficial de la Asociación Española de Pediatría ( AEP ), Vol. 87, Núm. 3, pp. 155-163

2014

  1. Cunninghamella bertholletiae infection in children: Review and report of 2 cases with disseminated infection

    Journal of Pediatric Hematology/Oncology, Vol. 36, Núm. 2

2013

  1. Defining "poor mobilizer" in pediatric patients who need an autologous peripheral blood progenitor cell transplantation

    Cytotherapy, Vol. 15, Núm. 1, pp. 132-137

  2. Management of children with brain tumors in paraguay

    Neuro-Oncology, Vol. 15, Núm. 2, pp. 235-241

2010

  1. Exercise during hematopoietic stem cell transplant hospitalization in children

    Medicine and Science in Sports and Exercise, Vol. 42, Núm. 6, pp. 1045-1053

  2. High-dose busulfan and melphalan as conditioning regimen for autologous peripheral blood progenitor cell transplantation in high-risk ewing sarcoma patients: A long-term follow-up single-center study

    Pediatric Hematology and Oncology, Vol. 27, Núm. 4, pp. 272-282

2009

  1. Intrathecal liposomal cytarabine in children under 4 years with malignant brain tumors

    Journal of Neuro-Oncology, Vol. 95, Núm. 1, pp. 65-69

  2. KIR-HLA receptor-ligand mismatch associated with a graft-versus-tumor effect in haploidentical stem cell transplantation for pediatric metastatic solid tumors

    Pediatric Blood and Cancer, Vol. 53, Núm. 1, pp. 120-124

  3. Peripheral blood progenitor cell collection adverse events for childhood allogeneic donors: Variables related to the collection and safety profile

    British Journal of Haematology, Vol. 144, Núm. 6, pp. 909-916

2008

  1. Intentional induction of mixed haematopoietic chimerism as platform for cellular therapy after HLA-matched allogeneic stem cell transplantation in childhood leukaemia patients

    British Journal of Haematology, Vol. 140, Núm. 3, pp. 340-343

2007

  1. End of life in a cross-cultural context - Immigrant children with end-stage cancer

    Medicina Paliativa, Vol. 14, Núm. 4, pp. 236-242

  2. Mesenchymal stem cells are of recipient origin in pediatric transplantations using umbilical cord blood, peripheral blood, or bone marrow

    Journal of Pediatric Hematology/Oncology, Vol. 29, Núm. 6, pp. 388-392

  3. Successful treatment of intracranial ependymoma with leptomeningeal spread with systemic chemotherapy and intrathecal liposomal cytarabine in a two-year-old child

    Journal of Neuro-Oncology, Vol. 83, Núm. 3, pp. 303-306

2006

  1. Mobilisation of mesenchymal cells into blood in response to skeletal muscle injury

    British Journal of Sports Medicine, Vol. 40, Núm. 8, pp. 719-722

  2. Terapias celulares en oncología

    Oncologia

  3. Veinte años de experiencia en el tratamiento de la leucemia linfoblástica aguda

    Anales de Pediatria, Vol. 65, Núm. 3, pp. 198-204

2005

  1. High-dose chemotherapy with autologous stem cell rescue for children with high risk and recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors

    Journal of Neuro-Oncology, Vol. 71, Núm. 1, pp. 33-38

2004

  1. Altas dosis de quimioterapia con trasplante de progenitores hematopoyéticos autólogos en el tratamiento de los tumores del sistema nervioso central en la edad pediátrica

    Oncologia, Vol. 27, Núm. 2, pp. 17-23